AVANAFIL

SynDRA canonical compound SYN0028810 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	PDE5A
Mechanism of action	Phosphodiesterase inhibitor
Indication	erectile dysfunction
Disease area	urology

All known targets

spedra
TA 1790
stendra
Avanafilo
TA-1790
Spedra
Stendra
Stendra (TN)
STENDRA
(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
CHEBI:66876
DR5S136IVO
(S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine
(S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide
4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
(S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2pyrimidinylmethyl)-5-pyrimidinecarboxamide
4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
5-Pyrimidinecarboxamide, 4-(((3-chloro-4-methoxyphenyl)methyl)amino)-2-((2S)-2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-
Avanafil [USAN:INN]
UNII-DR5S136IVO
Zepeed
ine-5-carboxamide
4-((3-Chloro-4-methoxybenzyl)amino)-2-((2S)-2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
Spedra (TN)
AVANAFIL [USAN]
Avanafil (USAN/INN)
AVANAFIL [INN]
AVANAFIL [MI]
AVANAFIL [VANDF]
AVANAFIL [MART.]
AVANAFIL [WHO-DD]
Avanafil 100 microg/mL in Acetonitrile:Dimethylsulfoxide
SCHEMBL118799
AVANAFIL [ORANGE BOOK]
GTPL7448
CHEMBL1963681
AMY1794
DTXSID50186727